NEW YORK (GenomeWeb) – Children's Hospital Oakland Research Institute (CHORI) announced today that one of its researchers has received a $13.2 million grant from the National Institute of General Medical Sciences to identify the genetic mechanisms that influence patient response to statin drugs.

To oversee the project, CHORI's Ronald Krauss and collaborators have established a Center for Pharmacogenomics in Precision Medicine, applying genomic, transcriptomic, and metabolomic tools to studies in cellular and animal models of cardiovascular disease, CHORI said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.

Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.

In Science this week: research regulation and reporting requirement reform, and more.

NPR reports that government and private insurers are being slow to cover recently approved CAR-T cell therapies.